MOMENTA PHARMACEUTICALS INC 4/A SEC Filings

Filed On	Filing
13 Aug 2019	Form 4/A: Beltramello Jo Ann, Chief HR and Inf. Officer Sold 608 shares ($7.1K)
13 Aug 2019	Form 4/A: Manning Anthony M., Chief Scientific Officer Sold 226 shares ($2.64K)
13 Aug 2019	Form 4/A: Fier Ian, Chief Mfg and Program Officer Sold 215 shares ($2.51K)
13 Aug 2019	Form 4/A: Kwon Young, SVP, Chief Business Officer Sold 636 shares ($7.42K)
14 May 2019	Form 4/A: Carvajal Alejandra, Chief Legal Officer Returned 4,724 shares to the issuer
27 Mar 2018	Form 4/A: Kaundinya Ganesh Venkataraman, COO & CSO Granted 50,000 Restricted Stock Units · Exercised 10,103 Stock Option (Right to Buy) ($74.9K)
27 Mar 2018	Form 4/A: Leicher Bruce, SVP & General Counsel Granted 45,000 Restricted Stock Units
14 Feb 2012	Form 4/A: Sulat James R, Director Received 3,000 shares by exercise or conversion ($44.4K)
24 May 2010	Form 4/A: Crane Alan L, Former Director Received 35,200 shares by exercise or conversion ($147K)
03 Feb 2010	Form 4/A: Leicher Bruce, SVP & General Counsel Sold 501 shares ($5.64K)
23 Nov 2009	Form 4/A: Leicher Bruce, SVP & General Counsel Sold 501 shares ($5.64K)
25 Jul 2007	Form 4/A: Reeders Stephen T, Director Granted 19,200 Stock Option (Right to buy)
18 Jul 2007	Form 4/A: Sasisekharan Ram, Director Granted 19,200 Stock Option (Right to buy)
17 Jul 2007	Form 4/A: Hutt Peter Barton, Director Granted 19,200 Stock Option (Right to buy)
17 Jul 2007	Form 4/A: Crane Alan L, Director Granted 19,200 Stock Option (Right to buy)
17 Jul 2007	Form 4/A: Langer Robert, Director Granted 19,200 Stock Option (Right to buy)
17 Jul 2007	Form 4/A: Barrett Peter, Director Granted 19,200 Stock Option (Right to buy)
17 Jul 2007	Form 4/A: Shapiro Bennett M, Director Disposed of 19,200 Stock Option (Right to buy) (Grant/Award Acquisition)
17 Jul 2007	Form 4/A: Clarke John K, Director Granted 19,200 Stock Option (Right to buy)
17 Jul 2007	Form 4/A: Fanucci Marsha, Director Granted 19,200 Stock Option (Right to buy)

Comments